Sicart Associates LLC increased its position in Pfizer Inc. (NYSE:PFE) by 81.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 44,665 shares of the biopharmaceutical company’s stock after purchasing an additional 20,000 shares during the quarter. Sicart Associates LLC’s holdings in Pfizer were […]
